(Q48244608)

9 February 2018

title

The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients (English)

1 reference

9 February 2018

1 reference

Wissam El-Hage

1

0 references

Christian Andres

Christian R Andres

7

0 references

Vincent Camus

Vincent Camus

8

0 references

Catherine Belzung

Catherine Belzung

5

0 references

Patrick Vourc'H

2

Patrick Vourc'h

1 reference

9 February 2018

Yadira Ibarguen-Vargas

6

Yadira Ibarguen-Vargas

1 reference

9 February 2018

author name string

Philippe Gaillard

3

1 reference

9 February 2018

Julie Léger

4

1 reference

9 February 2018

publication date

31 July 2014

1 reference

9 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

9 February 2018

volume

232

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

575-581

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-014-3694-z

exact match

0 references

cites work

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Antidepressants and neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Vulnerability to depression: what is the role of stress genes in gene x environment interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Mechanisms of antidepressant resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Comparison of escitalopram and paroxetine in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Essential role of brain-derived neurotrophic factor in adult hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Study of the serotonin transporter (SLC6A4) and BDNF genes in French patients with non syndromic mental deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Human biomarkers of rapid antidepressant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3694-Z

The value of psychiatric treatment: its efficacy in severe mental disorders.

21 January 2018

1 reference

12 December 2020

Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report

1 reference

12 December 2020

Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.

1 reference

12 December 2020

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

12 December 2020

Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients

1 reference

12 December 2020

The increasing burden of depression

1 reference

12 December 2020

High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression

1 reference

12 December 2020

10.1007/S00213-014-3694-Z

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018